Current Evidence and Future Perspectives of the Best Supplements for Cardioprotection: Have We Reached the Final

Farah Yasmin1, Syed Hasan Ali1, Aisha Naeem1

  • 1Department of Internal Medicine, Dow Medical College, Dow University of Health Sciences, 74200 Karachi, Pakistan.

Insights

Vitamin supplementation may impact cardiovascular disease (CVD) risk by combating oxidative stress and inflammation. This review evaluates vitamins

Area of Science:

  • Nutritional science and cardiovascular medicine
  • Focus on the role of vitamins in managing chronic diseases
  • Interdisciplinary approach to cardiovascular health

Background:

  • Cardiovascular disease (CVD) is a major global health burden, encompassing conditions like coronary artery disease, stroke, hypertension, and heart failure.
  • Atherosclerosis, a key driver of coronary artery disease, is influenced by modifiable risk factors including diet and exercise.
  • Oxidative stress and inflammation are implicated in the development of CVD, highlighting potential therapeutic targets.

Purpose of the Study:

  • To conduct a narrative review evaluating the benefits and risks of vitamin supplementation in patients with cardiovascular disease (CVD).
  • To explore the scientific evidence correlating vitamin intake with cardiovascular health outcomes.
  • To provide evidence-based recommendations for future research and clinical practice regarding vitamin supplementation in CVD management.

Main Methods:

  • Systematic literature search for studies on vitamin supplementation and CVD.
  • Narrative synthesis of findings from relevant research articles.
  • Critical evaluation of the quality and outcomes of included studies.

Main Results:

  • Vitamins possess anti-inflammatory and antioxidative properties, suggesting a potential role in CVD prevention and treatment.
  • Evidence regarding the efficacy and safety of various vitamin supplements in CVD patients is mixed and requires careful consideration.
  • Specific vitamins may offer benefits, but risks associated with high-dose supplementation need to be addressed.

Conclusions:

  • Vitamin supplementation presents a complex area in cardiovascular disease management, with potential benefits and risks.
  • Further research is needed to clarify the optimal use of specific vitamins for different CVD patient populations.
  • Personalized approaches considering individual nutritional status and CVD risk factors are crucial for guiding supplementation strategies.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
765
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
624
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555